Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Lease liabilities | 686 | 611 |
| Net cash used in operating activities | (75,170) | (60,342) |
| Cash flows from investing activities | ||
| Purchases of property and equipment, net | (967) | (1,330) |
| Purchases of marketable securities | (42,610) | (105,207) |
| Maturities of marketable securities | 162,529 | 186,354 |
| Net cash provided by investing activities | 118,952 | 79,817 |
| Cash flows from financing activities |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s capex?
- IDEAYA Biosciences, Inc. (IDYA) reported capex of $967K in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s capex changed year-over-year?
- IDEAYA Biosciences, Inc.'s capex decreased by 27.3% year-over-year, from $1.33M to $967K.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s capex?
- Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s capex has grown at a -2.7% compound annual growth rate (CAGR), from $2.64M to $2.37M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about IDEAYA Biosciences, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude